Nifty
Sensex
:
:
21995.85
72488.99
-152.05 (-0.69%)
-454.69 (-0.62%)

Pharmaceuticals & Drugs - API

Rating :
48/99

BSE: 540222 | NSE: LAURUSLABS

431.40
18-Apr-2024
  • Open
  • High
  • Low
  • Previous Close
  •  444.00
  •  446.10
  •  429.80
  •  443.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1453958
  •  6398.78
  •  471.00
  •  278.85

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 23,267.16
  • 127.01
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 25,287.60
  • 0.46%
  • 5.89

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 27.19%
  • 8.01%
  • 23.95%
  • FII
  • DII
  • Others
  • 25.98%
  • 11.43%
  • 3.44%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.94
  • 21.39
  • 7.86

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 22.83
  • 34.93
  • 0.53

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.36
  • 53.28
  • -6.91

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.72
  • 31.69
  • 32.92

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 5.55
  • 6.38
  • 7.55

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 16.29
  • 17.10
  • 18.93

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Mar 23
Mar 22
Var%
Net Sales
1,194.92
1,544.82
-22.65%
1,224.45
1,575.89
-22.30%
1,181.79
1,538.94
-23.21%
1,380.90
1,424.83
-3.08%
Expenses
1,013.50
1,141.25
-11.19%
1,036.58
1,126.98
-8.02%
1,015.07
1,084.77
-6.43%
1,095.36
1,028.12
6.54%
EBITDA
181.42
403.57
-55.05%
187.87
448.91
-58.15%
166.72
454.17
-63.29%
285.54
396.71
-28.02%
EBIDTM
15.18%
26.12%
15.34%
28.49%
14.11%
29.51%
20.68%
27.84%
Other Income
2.43
1.43
69.93%
1.78
1.11
60.36%
3.60
1.75
105.71%
1.71
1.29
32.56%
Interest
50.82
42.71
18.99%
42.39
40.11
5.68%
39.19
29.25
33.98%
53.10
30.55
73.81%
Depreciation
98.41
84.44
16.54%
93.37
81.84
14.09%
90.55
70.79
27.91%
87.01
65.74
32.35%
PBT
34.62
277.85
-87.54%
53.89
328.07
-83.57%
40.58
355.88
-88.60%
147.14
301.71
-51.23%
Tax
9.45
74.79
-87.36%
14.57
94.27
-84.54%
12.18
103.34
-88.21%
39.90
69.81
-42.84%
PAT
25.17
203.06
-87.60%
39.32
233.80
-83.18%
28.40
252.54
-88.75%
107.24
231.90
-53.76%
PATM
2.11%
13.14%
3.21%
14.84%
2.40%
16.41%
7.77%
16.28%
EPS
0.43
3.77
-88.59%
0.69
4.33
-84.06%
0.46
4.68
-90.17%
1.91
4.29
-55.48%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
4,982.06
6,040.55
4,935.57
4,813.51
2,831.72
2,291.92
2,056.17
1,904.65
1,777.58
1,326.59
1,159.72
Net Sales Growth
-18.12%
22.39%
2.54%
69.99%
23.55%
11.47%
7.96%
7.15%
34.00%
14.39%
 
Cost Of Goods Sold
2,404.99
2,729.67
2,133.89
2,107.62
1,382.88
1,224.80
1,056.02
989.29
1,000.15
821.27
720.43
Gross Profit
2,577.07
3,310.88
2,801.68
2,705.89
1,448.84
1,067.12
1,000.15
915.36
777.43
505.32
439.29
GP Margin
51.73%
54.81%
56.77%
56.21%
51.16%
46.56%
48.64%
48.06%
43.74%
38.09%
37.88%
Total Expenditure
4,160.51
4,448.36
3,513.14
3,262.83
2,267.17
1,935.93
1,642.85
1,497.01
1,415.38
1,131.46
956.09
Power & Fuel Cost
-
324.10
204.47
157.75
136.77
109.37
94.21
66.27
57.95
49.86
35.03
% Of Sales
-
5.37%
4.14%
3.28%
4.83%
4.77%
4.58%
3.48%
3.26%
3.76%
3.02%
Employee Cost
-
557.43
469.55
397.04
320.77
276.33
238.14
204.73
175.46
131.38
103.25
% Of Sales
-
9.23%
9.51%
8.25%
11.33%
12.06%
11.58%
10.75%
9.87%
9.90%
8.90%
Manufacturing Exp.
-
522.90
441.18
364.78
239.50
178.96
150.78
139.47
106.97
80.61
47.96
% Of Sales
-
8.66%
8.94%
7.58%
8.46%
7.81%
7.33%
7.32%
6.02%
6.08%
4.14%
General & Admin Exp.
-
151.15
146.49
133.28
114.23
97.48
73.17
65.42
49.09
28.39
27.30
% Of Sales
-
2.50%
2.97%
2.77%
4.03%
4.25%
3.56%
3.43%
2.76%
2.14%
2.35%
Selling & Distn. Exp.
-
116.14
101.98
91.65
61.53
31.96
24.09
22.65
16.49
12.46
12.54
% Of Sales
-
1.92%
2.07%
1.90%
2.17%
1.39%
1.17%
1.19%
0.93%
0.94%
1.08%
Miscellaneous Exp.
-
46.97
15.58
10.71
11.49
17.03
6.44
9.18
9.27
7.49
12.54
% Of Sales
-
0.78%
0.32%
0.22%
0.41%
0.74%
0.31%
0.48%
0.52%
0.56%
0.83%
EBITDA
821.55
1,592.19
1,422.43
1,550.68
564.55
355.99
413.32
407.64
362.20
195.13
203.63
EBITDA Margin
16.49%
26.36%
28.82%
32.22%
19.94%
15.53%
20.10%
21.40%
20.38%
14.71%
17.56%
Other Income
9.52
6.00
15.30
23.66
5.92
16.15
29.19
33.44
4.36
34.07
8.82
Interest
185.50
165.17
102.39
68.16
89.59
88.19
79.64
99.90
111.11
101.11
58.71
Depreciation
369.34
324.08
251.49
205.07
187.27
164.19
125.45
105.98
86.41
61.53
32.88
PBT
276.23
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
66.57
120.86
Tax
76.10
312.30
251.42
317.29
38.34
25.99
69.81
43.86
34.90
-1.55
23.64
Tax Rate
27.55%
28.16%
23.20%
24.39%
13.06%
21.70%
29.40%
18.65%
20.65%
-2.33%
19.56%
PAT
200.13
793.37
827.72
983.58
255.27
93.76
167.61
191.33
134.14
68.12
97.22
PAT before Minority Interest
195.53
796.64
832.43
983.82
255.27
93.76
167.61
191.33
134.14
68.12
97.22
Minority Interest
-4.60
-3.27
-4.71
-0.24
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
4.02%
13.13%
16.77%
20.43%
9.01%
4.09%
8.15%
10.05%
7.55%
5.13%
8.38%
PAT Growth
-78.28%
-4.15%
-15.85%
285.31%
172.26%
-44.06%
-12.40%
42.63%
96.92%
-29.93%
 
EPS
3.71
14.72
15.36
18.25
4.74
1.74
3.11
3.55
2.49
1.26
1.80

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
4,037.53
3,351.19
2,597.55
1,769.77
1,558.41
1,482.64
1,330.45
856.80
722.10
358.42
Share Capital
107.73
107.47
107.32
106.91
106.44
106.03
105.76
82.38
82.13
77.84
Total Reserves
3,917.72
3,234.55
2,485.31
1,658.23
1,446.60
1,370.75
1,218.84
771.47
637.03
277.22
Non-Current Liabilities
1,179.48
927.98
692.84
214.24
295.49
174.30
132.34
428.11
363.73
203.92
Secured Loans
761.42
596.34
429.16
165.02
258.71
141.66
124.56
353.61
303.68
188.17
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
106.13
0.00
0.00
Long Term Provisions
81.47
72.67
63.19
45.85
30.05
20.84
14.59
6.77
5.13
3.93
Current Liabilities
2,432.26
2,681.01
2,457.15
1,692.38
1,423.90
1,306.89
1,120.75
883.75
802.49
710.87
Trade Payables
710.65
876.37
1,178.69
615.63
488.31
312.33
263.10
247.61
230.81
227.47
Other Current Liabilities
640.75
839.73
367.25
261.47
244.50
231.26
199.11
141.05
133.34
164.25
Short Term Borrowings
995.77
910.72
886.12
790.51
684.21
758.52
644.17
481.42
431.63
312.18
Short Term Provisions
85.09
54.19
25.09
24.77
6.89
4.78
14.37
13.66
6.70
6.97
Total Liabilities
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.83
2,583.54
2,168.66
1,888.32
1,273.21
Net Block
3,408.62
2,652.47
2,170.62
1,726.34
1,629.07
1,480.80
1,229.93
1,021.03
801.01
499.27
Gross Block
4,802.52
3,750.20
3,027.97
2,387.71
2,105.42
1,793.75
1,418.58
1,106.33
986.17
623.32
Accumulated Depreciation
1,393.90
1,097.73
857.35
661.37
476.35
312.95
188.65
85.30
185.16
124.04
Non Current Assets
4,198.72
3,623.43
2,675.83
1,864.33
1,814.84
1,716.23
1,443.71
1,165.92
1,024.41
696.70
Capital Work in Progress
550.78
813.22
362.17
67.18
109.63
163.18
143.26
69.60
109.67
116.10
Non Current Investment
49.90
30.81
3.41
3.41
3.40
3.40
3.40
7.04
7.45
0.00
Long Term Loans & Adv.
160.58
84.11
108.52
40.80
25.58
29.36
25.95
29.22
93.94
68.50
Other Non Current Assets
28.84
42.82
31.11
26.60
47.16
39.50
41.17
39.03
12.34
12.82
Current Assets
3,461.68
3,344.61
3,074.86
1,812.06
1,462.96
1,247.59
1,139.82
1,002.73
862.27
574.81
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
1,684.81
1,760.30
1,575.45
905.22
681.94
584.78
509.05
487.09
475.50
328.10
Sundry Debtors
1,580.44
1,354.18
1,306.06
791.42
709.94
570.59
567.61
444.86
285.07
194.88
Cash & Bank
48.46
75.94
48.46
1.74
3.02
3.06
4.09
28.77
58.88
23.20
Other Current Assets
147.97
19.71
56.50
51.77
68.06
89.16
59.08
42.00
42.82
28.64
Short Term Loans & Adv.
108.90
134.48
88.39
61.91
35.22
58.63
25.01
23.86
22.75
19.80
Net Current Assets
1,029.42
663.60
617.71
119.68
39.05
-59.30
19.07
118.98
59.78
-136.06
Total Assets
7,660.40
6,968.04
5,750.69
3,676.39
3,277.80
2,963.82
2,583.53
2,168.65
1,888.32
1,273.21

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
993.90
911.10
733.00
347.42
297.66
342.49
331.99
181.97
-64.71
121.23
PBT
1,108.94
1,083.85
1,301.11
293.61
119.75
237.42
235.19
169.04
66.57
120.86
Adjustment
485.71
351.13
254.45
293.21
247.69
216.47
199.38
200.57
136.26
83.06
Changes in Working Capital
-315.26
-341.61
-594.06
-199.76
-44.46
-49.48
-52.45
-154.37
-250.72
-59.27
Cash after chg. in Working capital
1,279.39
1,093.37
961.50
387.06
322.99
404.41
382.12
215.23
-47.89
144.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-285.49
-182.27
-228.50
-39.64
-25.32
-61.91
-50.13
-33.26
-16.82
-23.42
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-996.06
-914.34
-940.99
-221.13
-252.88
-384.15
-288.67
-312.20
-396.95
-311.82
Net Fixed Assets
-572.62
-1,025.56
-572.84
-236.25
-254.84
-394.43
-354.15
-76.75
-353.86
Net Investments
-22.40
-42.83
-260.57
-0.01
-6.57
-1.22
-24.40
-7.01
-18.65
Others
-401.04
154.05
-107.58
15.13
8.53
11.50
89.88
-228.44
-24.44
Cash from Financing Activity
-26.64
30.26
254.70
-127.66
-44.77
42.24
-53.61
103.32
486.08
203.03
Net Cash Inflow / Outflow
-28.80
27.02
46.71
-1.37
0.02
0.59
-10.30
-26.91
24.42
12.44
Opening Cash & Equivalents
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53
15.11
2.67
Closing Cash & Equivalent
45.67
75.35
48.46
1.69
2.97
3.00
2.42
12.81
39.53
15.11

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
74.73
62.19
48.32
33.02
29.18
27.86
25.05
99.86
83.92
37.83
ROA
10.89%
13.09%
20.87%
7.34%
3.00%
6.04%
8.05%
6.61%
4.31%
7.64%
ROE
21.63%
28.05%
45.15%
15.39%
6.19%
11.97%
18.12%
18.65%
14.47%
33.42%
ROCE
22.97%
25.97%
39.82%
14.14%
8.22%
13.68%
16.52%
16.35%
13.74%
19.96%
Fixed Asset Turnover
1.41
1.46
1.78
1.26
1.18
1.29
1.53
1.73
1.66
1.87
Receivable days
88.66
98.37
79.52
96.76
101.97
100.40
95.66
73.56
65.47
61.02
Inventory Days
104.09
123.34
94.05
102.29
100.87
96.48
94.12
97.00
109.61
102.73
Payable days
106.10
175.76
155.37
145.69
72.80
61.13
59.14
58.52
69.29
86.77
Cash Conversion Cycle
86.64
45.95
18.21
53.36
130.03
135.75
130.64
112.05
105.79
76.98
Total Debt/Equity
0.49
0.52
0.56
0.60
0.67
0.66
0.64
1.20
1.14
1.54
Interest Cover
7.71
11.59
20.09
4.28
2.36
3.98
3.35
2.52
1.66
3.06

News Update:


  • Laurus Labs invests over Rs 99 crore in subsidiary
    19th Feb 2024, 12:13 PM

    The Company has infused further equity via rights issue keeping in view of the funds requirements of LSPL

    Read More
  • Laurus Labs enters into joint venture agreement with Krka
    29th Jan 2024, 12:41 PM

    In this JV Company, Krka will hold 51% and Laurus 49% shareholding

    Read More
  • Laurus Labs - Quarterly Results
    24th Jan 2024, 15:28 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.